NCT00258687 Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT00257465 Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00257205 CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy Status COMPLETED Phase PHASE3
NCT00246012 A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00237965 The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy Status COMPLETED Phase NA
NCT00221702 PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) Status COMPLETED Phase PHASE3
NCT00207298 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology Status COMPLETED Phase N/A
NCT00204581 Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases Status COMPLETED Phase PHASE2
NCT00204529 Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB Status COMPLETED Phase PHASE3
NCT00200577 Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma Status COMPLETED Phase PHASE3
NCT00199901 Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma Status COMPLETED Phase PHASE2
NCT00185302 Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00184288 Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. Status WITHDRAWN Phase N/A
NCT00184067 Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma Status TERMINATED Phase PHASE2
NCT00162123 A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies Status COMPLETED Phase PHASE2